Lilly ICOS LLC
Records under this name other than patents Lilly ICOS LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,550,479 | Modified Pictet-Spengler reaction and products prepared therefrom Formerly held Term ended Term ended Nov 17, 2024 · From the USPTO record | Term ended | Term ended Nov 17, 2024 | From the USPTO record |
| US 6,821,975 | Beta-carboline drug products Formerly held Term ended Term ended Nov 6, 2022 · From the USPTO record | Term ended | Term ended Nov 6, 2022 | From the USPTO record |
| US 6,841,167 | β-carboline pharmaceutical compositions Formerly held Term ended Term ended Apr 26, 2020 · From the USPTO record | Term ended | Term ended Apr 26, 2020 | From the USPTO record |
| US 6,943,166 | Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction Formerly held Term ended Term ended Apr 26, 2020 · From the USPTO record | Term ended | Term ended Apr 26, 2020 | From the USPTO record |
| US 7,182,958 | β-carboline pharmaceutical compositions Formerly held Term ended Ended no later than Apr 26, 2020 · From the USPTO record | Term ended | Ended no later than Apr 26, 2020 | From the USPTO record |
| US 7,115,621 | Chemical compounds Formerly held Lapsed on the fee record Ended Oct 3, 2018 · From the USPTO record | Lapsed on the fee record | Ended Oct 3, 2018 | From the USPTO record |
| US 6,911,542 | Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives Formerly held Lapsed on the fee record Ended Jun 28, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jun 28, 2017 | From the USPTO record |
| US 7,122,554 | Carboline derivatives Lapsed on the fee record Ended Oct 17, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 17, 2014 | From the USPTO record |
| US 6,462,047 | Carboline derivatives as cGMP phosphodiesterase inhibitors Formerly held Lapsed on the fee record Ended Oct 8, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 8, 2014 | From the USPTO record |
| US 7,105,506 | Tetracyclic compounds as PDE5-inhibitors Lapsed on the fee record Ended Sep 12, 2014 · From the USPTO record | Lapsed on the fee record | Ended Sep 12, 2014 | From the USPTO record |